EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C17H28N2O |
| Net Charge | 0 |
| Average Mass | 276.424 |
| Monoisotopic Mass | 276.22016 |
| SMILES | CCCN(CC)C(CC)C(=O)Nc1c(C)cccc1C |
| InChI | InChI=1S/C17H28N2O/c1-6-12-19(8-3)15(7-2)17(20)18-16-13(4)10-9-11-14(16)5/h9-11,15H,6-8,12H2,1-5H3,(H,18,20) |
| InChIKey | VTUSIVBDOCDNHS-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Application: | local anaesthetic Any member of a group of drugs that reversibly inhibit the propagation of signals along nerves. Wide variations in potency, stability, toxicity, water-solubility and duration of action determine the route used for administration, e.g. topical, intravenous, epidural or spinal block. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| etidocaine (CHEBI:4904) has role local anaesthetic (CHEBI:36333) |
| etidocaine (CHEBI:4904) is a amino acid amide (CHEBI:22475) |
| IUPAC Name |
|---|
| N-(2,6-dimethylphenyl)-2-[ethyl(propyl)amino]butanamide |
| INNs | Source |
|---|---|
| etidocaina | ChemIDplus |
| etidocaine | KEGG DRUG |
| etidocainum | ChemIDplus |
| Synonyms | Source |
|---|---|
| (+-)-2-(Ethylpropylamino)-2',6'-butyroxylidide | ChemIDplus |
| (+-)-N-(2,6-Dimethylphenyl)-2-(ethylpropylamino)butanamide | ChemIDplus |
| Manual Xrefs | Databases |
|---|---|
| 1097 | DrugCentral |
| C07530 | KEGG COMPOUND |
| D04095 | KEGG DRUG |
| Etidocaine | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| Reaxys:2741181 | Reaxys |
| CAS:36637-18-0 | NIST Chemistry WebBook |
| CAS:36637-18-0 | ChemIDplus |
| Citations |
|---|